124 related articles for article (PubMed ID: 9603488)
1. Plasmodium yoelii: differences in the transcription of the 235-kDa rhoptry protein multigene family in lethal and nonlethal lines.
Preiser PR; Jarra W
Exp Parasitol; 1998 May; 89(1):50-7. PubMed ID: 9603488
[TBL] [Abstract][Full Text] [Related]
2. A rhoptry-protein-associated mechanism of clonal phenotypic variation in rodent malaria.
Preiser PR; Jarra W; Capiod T; Snounou G
Nature; 1999 Apr; 398(6728):618-22. PubMed ID: 10217144
[TBL] [Abstract][Full Text] [Related]
3. Delineation of epitopes on the Py235 rhoptry antigen of Plasmodium yoelii YM.
Bayele HK; Brown KN
FEMS Immunol Med Microbiol; 2007 Aug; 50(3):389-95. PubMed ID: 17537175
[TBL] [Abstract][Full Text] [Related]
4. Plasmodium yoelii: combinatorial expression of variants of the 235 kDa rhoptry antigen during infection.
Bayele HK; Brown KN
Exp Parasitol; 2007 Aug; 116(4):354-60. PubMed ID: 17368448
[TBL] [Abstract][Full Text] [Related]
5. Distribution and characterisation of the 235 kDa rhoptry multigene family within the genomes of virulent and avirulent lines of Plasmodium yoelii.
Khan SM; Jarra W; Bayele H; Preiser PR
Mol Biochem Parasitol; 2001 May; 114(2):197-208. PubMed ID: 11378199
[TBL] [Abstract][Full Text] [Related]
6. Variable expression of the 235 kDa rhoptry protein of Plasmodium yoelii mediate host cell adaptation and immune evasion.
Iyer JK; Amaladoss A; Genesan S; Preiser PR
Mol Microbiol; 2007 Jul; 65(2):333-46. PubMed ID: 17590237
[TBL] [Abstract][Full Text] [Related]
7. Passive immunization with a multicomponent vaccine against conserved domains of apical membrane antigen 1 and 235-kilodalton rhoptry proteins protects mice against Plasmodium yoelii blood-stage challenge infection.
Narum DL; Ogun SA; Batchelor AH; Holder AA
Infect Immun; 2006 Oct; 74(10):5529-36. PubMed ID: 16988228
[TBL] [Abstract][Full Text] [Related]
8. Detection of Plasmodium yoelii stage mRNA in BALB/c mice.
Lau AO; Sacci JB; Azad AF
J Parasitol; 2001 Feb; 87(1):19-23. PubMed ID: 11227890
[TBL] [Abstract][Full Text] [Related]
9. Sequence diversity and antigenic polymorphism in the Plasmodium yoelii p235 high molecular mass rhoptry proteins and their genes.
Narum DL; Green JL; Ogun SA; Holder AA
Mol Biochem Parasitol; 2001 Feb; 112(2):193-200. PubMed ID: 11223126
[TBL] [Abstract][Full Text] [Related]
10. Isolation of merozoite rhoptries, identification of novel rhoptry-associated proteins from Plasmodium yoelii, P. chabaudi, P. berghei, and conserved interspecies reactivity of organelles and proteins with P. falciparum rhoptry-specific antibodies.
Sam-Yellowe TY; Del Rio RA; Fujioka H; Aikawa M; Yang JC; Yakubu Z
Exp Parasitol; 1998 Jul; 89(3):271-84. PubMed ID: 9676705
[TBL] [Abstract][Full Text] [Related]
11. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
Dobaño C; Doolan DL
Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
[TBL] [Abstract][Full Text] [Related]
12. Alteration in host cell tropism limits the efficacy of immunization with a surface protein of malaria merozoites.
Shi Q; Cernetich A; Daly TM; Galvan G; Vaidya AB; Bergman LW; Burns JM
Infect Immun; 2005 Oct; 73(10):6363-71. PubMed ID: 16177307
[TBL] [Abstract][Full Text] [Related]
13. [Studies on the antigens of invasive stages of Plasmodium yoelii and Plasmodium berghei].
Jin LQ; Luo JM; Fu YC; Xu SE; Guo Y; Xie LC; Tsuboi T; Torii M
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2003; 21(5):272-4. PubMed ID: 15108514
[TBL] [Abstract][Full Text] [Related]
14. Oral immunization with a combination of Plasmodium yoelii merozoite surface proteins 1 and 4/5 enhances protection against lethal malaria challenge.
Wang L; Goschnick MW; Coppel RL
Infect Immun; 2004 Oct; 72(10):6172-5. PubMed ID: 15385527
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterisation of RAMA homologues in rodent, simian and human malaria species.
Topolska AE; Black CG; Coppel RL
Mol Biochem Parasitol; 2004 Dec; 138(2):237-41. PubMed ID: 15555735
[No Abstract] [Full Text] [Related]
16. Transcriptional analysis of in vivo Plasmodium yoelii liver stage gene expression.
Sacci JB; Ribeiro JM; Huang F; Alam U; Russell JA; Blair PL; Witney A; Carucci DJ; Azad AF; Aguiar JC
Mol Biochem Parasitol; 2005 Aug; 142(2):177-83. PubMed ID: 15876462
[TBL] [Abstract][Full Text] [Related]
17. Expression, localization, and erythrocyte binding activity of Plasmodium yoelii merozoite surface protein-8.
Shi Q; Cernetich-Ott A; Lynch MM; Burns JM
Mol Biochem Parasitol; 2006 Oct; 149(2):231-41. PubMed ID: 16846654
[TBL] [Abstract][Full Text] [Related]
18. Plasmodium yoelii yoelii 17XL MSP-1: fine-specificity mapping of a discontinuous, disulfide-dependent epitope recognized by a protective monoclonal antibody using expression PCR (E-PCR).
Farley PJ; Long CA
Exp Parasitol; 1995 Mar; 80(2):328-32. PubMed ID: 7534725
[No Abstract] [Full Text] [Related]
19. Prophylactic potential of liposomized integral membrane protein of Plasmodium yoelii nigeriensis against blood stage infection in BALB/c mice.
Sharma SK; Gupta C; Dwivedi V; Misra-Bhattacharya S; Mohammad O
Vaccine; 2007 Mar; 25(11):2103-11. PubMed ID: 17241709
[TBL] [Abstract][Full Text] [Related]
20. Targeted disruption of py235ebp-1: invasion of erythrocytes by Plasmodium yoelii using an alternative Py235 erythrocyte binding protein.
Ogun SA; Tewari R; Otto TD; Howell SA; Knuepfer E; Cunningham DA; Xu Z; Pain A; Holder AA
PLoS Pathog; 2011 Feb; 7(2):e1001288. PubMed ID: 21379566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
